Drug Type Biosimilar, Monoclonal antibody |
Synonyms Trastuzumab Biosimilar (PT Kalbe Genexine Biologics), 曲妥珠单抗生物类似药(PT Kalbe Genexine Biologics) |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hormone receptor negative HER2 positive breast cancer | ID | 30 Nov 2022 | |
Metastatic breast cancer | ID | 30 Nov 2022 | |
Stomach Cancer | ID | 30 Nov 2022 |